|
Jul 21
|
Why Alkermes Tumbled On Its Positive Narcolepsy Study
|
|
Jul 15
|
Centessa Pharmaceuticals Advances Neurological Drug ORX142 to Clinical Trials
|
|
Jun 24
|
Centessa Pharmaceuticals Receives FDA Clearance for New Drug ORX142, Initiates Phase 1 Study
|
|
Jun 24
|
Centessa Pharmaceuticals plc's (NASDAQ:CNTA) Intrinsic Value Is Potentially 99% Above Its Share Price
|
|
May 14
|
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025
|
|
May 5
|
Is Centessa Pharmaceuticals plc (CNTA) the Best Small Cap Stock to Buy with the Biggest Upside Potential?
|
|
Jan 1
|
Centessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Could Be 30% Below Their Intrinsic Value Estimate
|